MoneyWorks4Me

Lupin informs about press release

13 May 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, launch of Tolvaptan Tablets, 15 mg, 30 mg, 45 mg, 60 mg and 90 mg, in the United States, following the recent approval received from the US FDA.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..